Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.

Cancer immunology, immunotherapy : CII - 1 Jun 2012

De Costa Anna-Maria A, Schuyler Corinne A, Walker David D, Young M Rita I

Abstract excerpt

While studies have indicated that squamous cell carcinoma of the head and neck (HNSCC) is associated with immune suppression, these studies did not analyze the immune response at the dysplastic stage. The present study utilized a mouse model of 4-nitroquinoline 1-oxide-induced oral carcinogenesis to examine the alterations in immune phenotype at the premalignant and malignant stages of HNSCC. Cervical lymph nodes...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Squamous Cell
Share to Disease Progression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Head and Neck Neoplasms

Share to Mice, Inbred C57BL

Share to T-Lymphocytes, Cytotoxic

Share to Th1 Cells

Share to Th17 Cells

Source

Open in PubMed Open full text

Identifiers

PMID: 22116344
DOI: 10.1007/s00262-011-1154-8
PMCID: PMC5925419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Characterization of the evolution of immune phenotype during the development and progression of squamous cell carcinoma of the head and neck.PMID 22116344Read ↗

Genomic and Transcriptomic Landscape of an Oral Squamous Cell Carcinoma Mouse Model for ImmunotherapySemantic proximity Read ↗

Treatment to sustain a Th17-type phenotype to prevent skewing toward Treg and to limit premalignant lesion progression to cancer.Semantic proximity Read ↗

Decreased expression of CD80 is a marker for increased tumorigenicity in a new murine model of oral squamous-cell carcinoma.Semantic proximity Read ↗

Novel syngeneic animal model of tobacco-associated oral cancer reveals the activity of <i>in situ</i> anti-CTLA-4Semantic proximity Read ↗

A Novel Syngeneic Mouse Model to Study Immune Evasion in Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neckSemantic proximity Read ↗

HPV-positive murine oral squamous cell carcinoma: development and characterization of a new mouse tumor model for immunological studiesSemantic proximity Read ↗

Comparative analysis of tumor-infiltrating lymphocytes in a syngeneic mouse model of oral cancer.Semantic proximity Read ↗

Genomic landscape and clonal architecture of mouse oral squamous cell carcinomas dictate tumour ecology.Semantic proximity Read ↗

p53 Transgenic mice are highly susceptible to 4-nitroquinoline-1-oxide-induced oral cancer.Semantic proximity Read ↗

Human papillomavirus type 16 E6 and E7 oncoproteins act synergistically to cause head and neck cancer in miceSemantic proximity Read ↗

Transient immunological and clinical effectiveness of treating mice bearing premalignant oral lesions with PD-1 antibodies.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.